NEW YORK (GenomeWeb) – The Jackson Laboratory announced last week that it has won a $1.4 million grant from the US Department of Defense (DoD) to develop a new method for classifying triple-negative breast cancer (TNBC) tumors, which could lead to the development of better diagnostics and precision treatments.
Get the full story This story is free
for registered users
Registering provides access to this and other free content.
Already have an account?